John Bashkin is the principal at Bashkin Consulting (Fremont, CA), where he advises early-stage companies on corporate strategy and agreements, financing, intellectual property, SBIR grants, and business plans. He is listed as a coinventor on six issued U.S. patents and has coauthored more than 20 articles. Reach him at jbashkin@comcast.net.

Anna Berkovich is president of Russamer Lab (Pittsburgh). She specializes in finishing medical implants, instruments, and invasive devices. Berkovich has worked on cobalt-chrome knee implants, disposable invasive titanium devices, and nitinol wire and stents. She can be contacted at admin@russamer.com.

Harry F. Bushar is a statistical consultant for CDRH Office of Surveillance and Biometrics, Division of Biostatistics. At CDRH, he has provided critical evaluations of premarket submissions, collaborated on research projects and epidemiological studies, and done risk assessments to support compliance actions. E-mail him at harrybushar@verizon.net.

Debbie Donovan is a marketing and sales consultant at eGold Solutions (Mountain View, CA), where she focuses on developing digital marketing programs for medical technology companies. Donovan holds a bachelor’s degree in public relations journalism from the University of Southern California. Reach out to her at deb@egoldsolutions.com.

John B. Kowalski is a principal consultant with SteriPro Consulting (Corona, CA), a division of Sterigenics International Inc. (Oak Brook, IL). He has worked in absorbable medical devices, sterilization microbiology, and sterilization process development and validation with moist and dry heat. Kowalski can be contacted at jkowalski@sterigenics.com.

Gregg Mosley is president and founder of Biotest Laboratories Inc. (Minneapolis). He has 40 years of experience as a microbiologist, chemist, and biochemist in academic and industry positions and cochairs the AAMI Biological Indicators and Industrial Moist Heat Sterilization committees. Get in touch with him at gmosley@biotestlabs.com.

Kevin O’Keeffe is an associate principal in the life sciences practice at Charles River Associates (Boston). He advises medtech companies on new product development and licensing and manages due diligence engagements on behalf of medtech investors. Reach O’Keeffe at kokeeffe@crai.com.

Kent Royer is director of global medical business development at Milacron Inc. (Batavia, OH), where he has worked with the Roboshot product line for 26 years. His background is in development of electric machines, and he has done development work in LSR and other cleanroom applications. Royer can be e-mailed at kent_royer@milacron.com.